Sunshine Biopharma, Inc.
SBFM
$1.05
$0.021.94%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.14M | -883.80K | -1.77M | -1.18M | -2.16M |
| Total Depreciation and Amortization | 98.60K | 96.20K | 72.50K | 64.80K | 65.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 142.00K | 554.70K | 1.06M | -- | 0.00 |
| Change in Net Operating Assets | 284.30K | -494.80K | -636.90K | -598.90K | -1.31M |
| Cash from Operations | -1.62M | -727.80K | -1.27M | -1.71M | -3.41M |
| Capital Expenditure | 1.00K | -8.00K | -160.00K | -7.50K | -102.60K |
| Sale of Property, Plant, and Equipment | -10.30K | 10.30K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -41.00K | -120.50K | -331.80K | -168.50K | 4.80K |
| Cash from Investing | -50.20K | -118.30K | -491.80K | -176.00K | -97.80K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 75.50K | -58.40K | -17.20K | -- |
| Issuance of Common Stock | 724.50K | 0.00 | 3.67M | 355.30K | 1.62M |
| Repurchase of Common Stock | -- | -- | -- | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 724.50K | 75.50K | 3.61M | 338.10K | 1.62M |
| Foreign Exchange rate Adjustments | 758.60K | -228.30K | 335.70K | -10.20K | -635.30K |
| Miscellaneous Cash Flow Adjustments | -- | 0.00 | 0.00 | -- | -- |
| Net Change in Cash | -183.10K | -998.90K | 2.18M | -1.56M | -2.52M |